PROGRAMS
Fetal Treatment Program - Since the Fall of 1999, the Center for Fetal Medicine and Prenatal Genetics has been actively involved in a collaborative effort with Children's Hospital on Fetal Therapy. The program encompasses infants who require modifications of their antepartum or delivery plans, as well as those infants requiring invasive procedures before birth, such as laser or fetal surgeries. With referrals from within New England as well as nationwide, the program provides the coordination and specialty services needed for the fetal therapies increasingly applicable to a growing number of conditions including Hypoplastic Left Heart Syndrome, twin-twin transfusion, fetal airway obstruction, and congenital diaphragmatic hernia. This collaborative program provides seamless coordination and treatment for infants with a diversity of fetal conditions.
Fetal Cardiac Intervention Program - Designed for fetal cardiac disease of an obstructive nature, in-utero valve dilation is proving successful in halting the progression of hypoplastic left heart disease. Expansion to septoplasty and pulmonic valve dilation is anticipated.
Preimplantation Genetic Diagnosis - With successes in the arena of translocation carriers and sex determination for X-linked disorders, this program offers women of advanced maternal age screening for chromosome abnormalities. Evaluation and testing for DNA based, single gene disorders can be initiated through the program.
Genetic Counseling Program - while continuing to be actively involved in one to one counseling for the Center for Fetal Medicine and Prenatal Genetics, current programs are being initiated to further utilize both their teaching and counseling backgrounds. Advances in the decoding of the human genome now place genetic testing, as well as the interpretation and application of these tests in the physicians' office. Programs taught by the genetic counselors to physician office staff supports implementation of prenatal genetic services to the obstetric community.
"First Look" Program: Establishment of a first trimester screening program for women at increased risk of birth defects, chromosomal abnormalities and certain inherited diseases. Based on ultrasound and a maternal blood sample, this screening will provide at-risk women access to early diagnosis and potential treatments.
Send Feedback to: 
